Search Results - "Dielschneider, R F"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism by Dielschneider, R F, Eisenstat, H, Mi, S, Curtis, J M, Xiao, W, Johnston, J B, Gibson, S B

    Published in Leukemia (01-06-2016)
    “…Lysosome membrane permeabilization (LMP) mediates cell death in a variety of cancer cells. However, little is known about lysosomes and LMP in chronic…”
    Get full text
    Journal Article
  2. 2

    Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling by Dielschneider, R F, Xiao, W, Yoon, J-Y, Noh, E, Banerji, V, Li, H, Marshall, A J, Johnston, J B, Gibson, S B

    Published in Cell death & disease (01-10-2014)
    “…Chronic lymphocytic leukemia (CLL) can be divided into groups based on biomarkers of poor prognosis. The expression of the tyrosine kinase ZAP-70 (member of…”
    Get full text
    Journal Article
  3. 3

    Abstract 5423: ZAP70 alters metabolism in chronic lymphocytic leukemic cells by Das, Subhadip, Dielschneider, RF, Henson, Elizabeth S., Gibson, Spencer B.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Chronic lymphocytic leukemia (CLL) has the highest incidence among adults in western countries. Prognosis of CLL is highly variable but one of the…”
    Get full text
    Journal Article